June 18, 2018
Rose
The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes.
from MobiHealthNews https://ift.tt/2JY1LcV
June 18, 2018
Rose
MobiHealthNews
No comments
Related Posts:
New app WeMa aims to give resources to caregivers- iTriage, an early mobile health success, shuts down as Aetna preps for new flagship app
- Mayo Clinic finds IBM Watson increases enrollment of clinical trials
- HHS seeing ‘culture change’ when it comes to data sharing
- Canadian startups show off array of digital health tools
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment